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Side-chain oligo- and polyglutamylation represents an important posttranslational modiﬁcation in tubulin physiology. The
particular number ofglutamateunits is related to speciﬁc regulatory functions. In this work,we present a method forthe synthesis
ofbuilding blocksfortheFmocsynthesisofpeptides containingmainchainglutamicacidresidues thatcarryside-chainbranching
with oligo-glutamic acid. The two model peptide sequences CYEEVGVDSVEGEG-E(Ex)-EEGEEY and CQDATADEQG-E(Ex)-
FEEEEGEDEA from the C-termini of mammalian α1- and β1-tubulin, respectively, containing oligo-glutamic acid side-chain
branching with lengths of 1 to 5 amino acids were assembled in good yield and purity. The products may lead to the generation of
speciﬁc antibodies which should be important tools for a more detailed investigation of polyglutamylation processes.
1.Introduction
Enzymatic side-chain oligoglutamylation of tubulin was ﬁrst
reported in 1990 [1]. It is an important posttranslational
modiﬁcation for the regulation of cellular functions like
mitosis and axonal growth [2, 3]. This process has been
termed side-chain “polyglutamylation,” which is somewhat
misleading, since the number of side-chain glutamic acids
is small in most cases and seems generally to be well
deﬁned. The length of the oligo-Glu side chain can vary
between 1 and 20, and possibly even more residues and ﬁne
tuning of protein interactions seems to depend critically on
the exact number of the Glu units. Although proteomics
approaches have shown that more than 100 proteins are
modiﬁed this way [4], as yet very little is know about this
process. One of the obstacles in the investigations is the
lack of speciﬁc antibodies that can discriminate between
the diﬀerent lengths of the oligo-Glu modiﬁcations. So
far mainly the monoclonal antibody GT335 [5] has been
used in studies of side-chain oligo- and polyglutamylation
of proteins. The antibody was generated with a peptide
containing a branching with two glutamic acids. The pep-
tide had been obtained by chemical Boc synthesis with
the coupling of benzyl-protected di-glutamic acid to a selec-
tively deprotected Glu side chain by on-resin activation with
N-hydroxy-succinimide and carbodiimide [6]. Although the
antibody GT335 is valuable for the identiﬁcation of side-
chain glutamylation in general, it is insensitive to the length
of the modiﬁcation. For many investigations in this ﬁeld, the
availability antibodies that are speciﬁc to the length of the
side chain would be highly advantageous.
For the generation of such antibodies, the synthesis
of peptides with corresponding deﬁned side chains is
mandatory. We have investigated two diﬀerent strategies for
the chemical Fmoc synthesis of peptides containing oligo-
Glu branching. Firstly the incorporation of the main chain
glutamic acid with a selectively cleavable allyl side-chain
protection, followed by selective deprotection, activation
of the carboxylic group on the resin, and the coupling
of H-Glu(tBu)-Oallyl with further side-chain elongation
after allyl cleavage, similar to the Boc method published
before. Secondly the preassembling of suitably protected
building blockswith the required side-chain length and their
utilization in the assembly of the main chain.
The ﬁrst strategy turned out to be not suitable, since
according to HPLC and MALDI analysis only one or two2 International Journal of Peptides
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Figure 1: General reaction scheme for the synthesis of the Fmoc-protected building units for solid-phase peptide synthesis (x = 1t o5 ,
corresponding to the incrementations a to e of the numbering of the compounds).
side-chain Glu residues couldbe introduced, and eventhat is
not reliable (data not shown). The second procedure proved
to be much more useful, and the desired sequences were
obtained in good yield and purity. This strategy is described
in detail below (Figure 1).
Synthesis of the building blocks was carried out by ﬁrst
immobilizing Fmoc-Glu(tBu)-OH on chlorotrityl chloride
resin (1), followed by elongation with the required number
of the same building block, and ﬁnally coupling of Fmoc-
Glu-Oallyl via its side-chain carboxyl function (2a–e). After
cleaving the protected peptides from the support by the use
of mild acid (2% triﬂuoroacetic acid in dichloro methane),
the resulting free carboxylic function of 3a–e was esteriﬁed
by treatment with t-butyl 2,2,2-trichloroacetimidate by a
modiﬁcation of the method by Armstrong et al. [7]. The
authors have used the Lewis acid boron triﬂuoride etherate
as a catalyst. Although in other investigations Fmoc amino
acids appeared stable towards boron triﬂuoride etherate
[8], we experienced loss of compounds 3a–e with no
product formation under those conditions. Introduction
of the t-butyl group proceeded smoothly without boron
triﬂuoride etherate, though, after treatment with t-butyl
2,2,2-trichloroacetimidate over an extended time period in
the presence of acetic acid. The side reaction of esteriﬁ-
cation of the acetic acid with the reagent t-butyl 2,2,2-
trichloroacetimidate was counterballanced by the use of a
tenfoldexcessofthet-Butransfer reagentovertheamount of
peptide. In the presence of acetic acid, the reaction smoothly
went to completion to yield the compounds 4a–e within one
to two days. Finally cleavage of the allyl function with the
palladium catalyst tetrakis(triphenylphospine)palladium(0)
a n d1 , 3 - d i m e t h y l b a r b i t u r i ca c i dr e s u l t e di nt h ed e s i r e dp r o d -
ucts 5a–e without indication of a loss of the Fmoc group.
Model peptides corresponding to the C-terminal se-
quences of mammalian α1-tubulin (CYEEVGVDSVEGEGE
EEGEEY) and β2-tubulin(CQDATADEQGEFEEEEGEDEA)
with an extra cysteine at the N-terminus for immobilization
were assembled that contain oligo-Glu side chains of 1 to
5 residues at positions 15 and 11, respectively (underlined).
Fmoc peptide synthesis protocols were employed (Figure 2),
and the preassembled olig-Glu building blocks were used in
twofoldexcesswith couplingtimesof18hours. Theproducts
were obtained in good yield and purity and are currently
used in the generation of speciﬁc antibodies.
The procedure described in this study should facilitate
the synthesis of diﬀerent oligo-Glu side-chain modiﬁed
peptides and should open new approaches that lead to a
better understanding of the fundamental process of side-
chain oligoglutamylation.
2.Experiments
2.1. Resin Loading. Chloro-(2 -chloro)trityl polystyrene
resin (capacity1.09mmol/g, RappPolymere,T¨ ubingen,Ger-
many) was treated with Fmoc-Glu(OtBu)-OH (anhydrous,
1.5mmol/g resin) and DIPEA (6 mmol/g resin) in dry DCM
for 18h. After washing with DMF, the Fmoc group was
cleavedwith20%piperidineinDMF,andthedibenzofulveneInternational Journal of Peptides 3
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Figure 2: Scheme for the assembly of the carboxy-terminal sequence of α1-tubulin containing a side-chain oligo-glutamic acid branched
glutamic acid at position 15 of the sequence. The corresponding β1-tubulin peptides (CQDATADEQG-E(Ex)-FEEEEGEDEA) were
assembled accordingly (x = 1 to 5, corresponding to the incrementations a to e of the numbering of the compounds).
adduct was quantiﬁed photometrically [9]. A loading of
660μmol/g dry resin was determined.
2.2. Assembly of the Precursors 3a–e (General Procedure). To
the tritylchloride resin with attached Fmoc-Glu(OtBu) 1
(500μmole), the required numbers of Fmoc-Glu(OtBu)-OH
units (0–4) were coupled in a 5-fold excess by activation
with TBTU (1 equivalent) and DIPEA (2 equivalents) in
DMF for 2 hours, in each case followed by a Fmoc cleavage
with 20% piperidine in DMF over 10min. Finally Fmoc-
Glu-Oallyl was coupled with the same activation strategy.
The solid supports with the attached products were treated
with 100ml of 2% TFA in DCM in portions of 5 ml over a
period of 6 hours and the ﬁltrate collected in 200ml of DMF.
After evaporation of the solvents, the residues were dissolved
in 40 ml of dioxane and lyophlilized three times to give the
products 3a–e as white powders in yields of 95–98%. NMR
(CD2Cl2) of 3a exemplarily for the group: 7.83–7.74 (2 H, d,
Fmoc), 7.69–7.56 (2 H, d, Fmoc), 7.48–7.38 (2 H, t, Fmoc),
7.38–7.29 (2 H, t, Fmoc), 7.08–6.97 (1 H, d, NH), 6.04–5.85
(2 H, m, NH and –CH=C allyl), 5.40–5.20 (2 H, m (together
with CHDCl2), =CH2 allyl), 4.70–4.59 (2 H, d, –CH2–allyl),
4.59–4.30 (4 H, m, 2x Cα and –CH2–O Fmoc), 4.30–4.18 ( 1
H, t, CH Fmoc), 2.52–1.89 (8 H, m, 2x–CH2–CH2–G l us i d e
chain), 1.50–1.40 (9 H, –CH3 tBu).
2.3. Formation of the t-Butyl Esters 4a–e (General Procedure).
The above products in amounts corresponding to
500μmole were dissolved in 10ml of DCM, and 40ml
of cyclohexane was added. After the addition of tert-butyl
2,2,2-trichloroacetimidate (1.79ml, 5mmole) and acetic
acid (572μl, 10mmole), the mixtures were stirred for 24h
to 48h at room temperature with occasional control by
analytical HPLC (Phenomenex Gemini 5μm, 50 × 2m m
column with a gradient of 5% acetonitrile in water to 100%
acetonitrile containing 0.1% TFA). After completion of the
reaction, the organic layer was extracted three times with 0.1
N HCl and dried with magnesium sulfate. The solvents were
removed, and the crude products were puriﬁed by HPLC
on a 250 × 40 mm Nucleosil C18 100-7 column (Macherey-
Nagel, D¨ uren, Germany) with gradients from 50% methanol
in water to 100% methanol at 25ml/min in 1h. The
products 4a–e were obtained in yields of 80-90%. NMR
(CD2Cl2)o f4a exemplarily for the group: 7.82–7.75 (2 H, d,
Fmoc), 7.67–7.58 (2 H, d, Fmoc), 7.43–7.37 (2 H, t, Fmoc),
7.37–7.29 (2 H, t, Fmoc), 6.46–6.37 (1 H, d, NH), 5.99–5.86
(1 H, m, –CH=C allyl), 5.86-5.79 (1 H, d, NH), 5.38-5.21
(2 H, m (together with CHDCl2), =CH2 allyl), 4.68-4.58 (2
H, d, –CH2– allyl), 4.47–4.28 (4 H, m, 2x Cα and –CH2–O
Fmoc), 4.28–4.19 (1 H, t, CH Fmoc), 2.36–1.83 (8 H, m, 2x
–CH2–CH2– Glu side chain), 1.52–1.33 (18 H, –CH3 tBu).
2.4. Cleavage of the Allyl Group. Amounts given for
100μmole peptide: Cleavage of the allyl group was carried
out by dissolvingtetrakis(triphenylphospine)palladium(0)4 International Journal of Peptides
(11.5mg, 10μmole) and 1,3-dimethylbarbituric acid
(15.6mg, 100μmole) in an argon-saturated mixture of
DMF (5ml) and THF (2ml). The solution was added to the
peptide under argon atmosphere, and the mixture was kept
for 18h in the dark at room temperature. Completion of
the cleavage of the allyl group was conﬁrmed by analytical
HPLC. The solvents were removed by evaporation and,
the residues were taken up in ethyl acetate and extracted
three times with 0.1 N HCl. The organic layer was dried
with magnesium sulfate and evaporated to yield the
crude products 5a–e, which were puriﬁed by preparative
HPLC on a 250 × 40mm Nucleosil C18 100-7 column
(Macherey-Nagel, D¨ uren, Germany) with a gradient from
50% methanol in water to 100% methanol at 25ml/min in
1h. NMR analyses (CDCl3) showed the disappearance of
the allyl signals at 4.60ppm–4.68 ppm (2 H, d, O–CH2–),
5.20–5.38 (2 H, dd, C=CH2) and 5.81ppm–5.98ppm (1
H, m, –CH=C). The products had purities of 90% to 95%
as judged by analytical HPLC. Product yields of 80%–90%
were obtained. Mass analyses (Bruker Daltonics MALDI,
calculations are reported for monoisotopic masses): 5a: calc.
for C33H42N2O9: 610.29, found: 633.15 (M+Na)+;5 b :c a l c .
for C42H57N3O12: 795.39, found: 818.33 (M+Na)+;5 c :
calc. for C51H72N4O15: 980.50, found: 1003.40 (M+Na)+;
5d: calc. for C60H87N5O18: 1165.60, found: 1188.50
(M+Na)+; 5e: calc. for C79H102N6O21: 1350.71, found:
1373.65 (M+Na)+.
2.5. Incorporation of the Oligo-Glu Building Blocks 5a–e
into the Peptide Sequences. For the α1-tubulin series the
peptide EEGEEY was synthesized on a 250μmole scale
on TentaGel S PHB-Tyr(tBu)-Fmoc resin with a pioneer
automated peptide synthesizer (Applied Biosystems, Foster
City, USA) with TBTU/DIPEA for activation and a fourfold
excess of amino acids. Coupling time was two hours. The
resin was washed with DCM, dried, and divided into ﬁve
equal portions of 50μmole. To each of these portions,
two equivalents of the diﬀerent building blocks 5a–e were
coupled by activation with TBTU (1 equivalent) and DIPEA
(2 equivalents) in DMF over 18h. After test cleavages of
5mg of the resulting material (95% TFA, 3% triisopropy-
lsilane, 2% water), which unequivocally showed complete
incorporationofthebuildingblocks,theremainingsequence
(CYEEVGVDSVEGEG) was assembled on a Syro Multiple
Peptide Synthesizer (MultiSyn Tech, Witten, Germany) by
employing TBTU/DIPEAforactivation and 1-hour coupling
times. After washing the resin with DCM, the peptides
were cleaved from the support and deprotected by a 4
h treatment with TFA/triisopropylsilane/water (95:3:2),
precipitated with t-butylmethyl ether, and characterized by
HPLC(PhenomenexGemini 5μm,50×2mmcolumnwitha
gradient of 95% water to 100% acetonitrile containing 0.1%
TFA) and MALDI mass spectrometry.
The β2-tubulin peptides were generated accordingly by
preassembling the sequence FEEEEGEDEA on TentaGel S
PHB-Ala Fmoc, manually coupling the oligo-Glu building
units 5a–e in a twofold excess, and ﬁnally assembling the
sequence CQDATADEQG on a Syro Multiple peptide syn-
thesizer. All conditions for synthesis, workup, and analysis
are asdescribedabove.Allmass analyses obtainedbyMALDI
corresponded to the expected values.
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